Abstract
Objective: To identify the contribution of physical therapy to individuals with ASD, mapping strategies, effects, and clinical implications. Methods: Integrative review (2019–2026) in PubMed/MEDLINE, Web of Science, Cochrane Library, SciELO, and LILACS (Portuguese/English/Spanish); eligibility: physiotherapy/physical activity interventions with motor/functional/participation outcomes; reporting according to PRISMA 2020. Results: 847 records identified; after removing 214 duplicates, 633 were screened; 65 assessed in full text; 52 excluded for ineligible design/case reports/editorials (n=15), unclear physiotherapy intervention (n=12), biomarker/pharmacology focus (n=10), high risk of bias/incomplete data (n=9), or out-of-range age/uncertain diagnosis (n=6). Thirteen studies were included (RCTs, quasi-experimental, and reviews), consistently improving balance, coordination, and fundamental motor skills; mind-body formats, team sports, and exergames emerged as promising, especially under adequate dose. Final considerations: Physical therapy supports motor gains and, in some studies, participation and sociability when delivered through regular, individualized programs sensitive to sensory profiles. Multicenter trials with standardized dose/outcomes and ≥3–6-month follow-up are warranted.
